Scientists found that nasal cells act as a first line of defense against the common cold, working together to block ...

Since its first approval in 2022, Gilead Sciences’ lenacapavir—a twice-yearly injectable—has come to be a potential game ...

When a rhinovirus, the most frequent cause of the common cold, infects the lining of our nasal passages, our cells work ...

Lenacapavir (LEN) is an antiviral medication used to treat and prevent HIV/AIDS and was first approved for individuals with ...

Your chances of catching a cold—and how miserable it feels—may depend more on your body than on the virus itself.

A new study shows that the body’s early immune response, not the virus itself, often determines how severe a rhinovirus cold ...

Baculoviruses are a diverse group of insect viruses that have long served as both biological control agents in agriculture and versatile tools in biotechnology. Their life cycle is marked by two ...

Across the world, only a few dozen people appear to carry a genetic glitch that lets them brush off viruses that flatten ...